Based on the Elevance Health Inc stock forecast from 10 analysts, the average analyst target price for Elevance Health Inc is USD 511.33 over the next 12 months. Elevance Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Elevance Health Inc is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, Elevance Health Inc’s stock price was USD 385.10. Elevance Health Inc’s stock price has changed by -1.07% over the past week, -1.44% over the past month and -24.81% over the last year.
No recent analyst target price found for Elevance Health Inc
No recent average analyst rating found for Elevance Health Inc
Company Overview Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana. Read Less
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to ...Read More
Frequently Asked Questions About Elevance Health Inc (ELV) Stock
Based on ratings from 10 analysts Elevance Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 13 buy, sell and 4 hold ratings.
ELV stock's dividend yield is 1.67%.
Our analysis grades ELV stock's dividend yield at A+. This means that ELV stock's dividend yield is above 100% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this ELV may be a good dividend stock for its sector.
Based on targets from 10 analysts, the average taret price for ELV is USD 511.33 over the next 12 months. The maximum analyst target price is USD 615 while the minimum anlayst target price is USD 388.
ELV stock's Price/Earning ratio is 15.24.
Our analysis grades ELV stock's Price / Earning ratio at F. This means that ELV stock's Price/Earning ratio is above 60% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this ELV may be a overvalued for its sector.
The last closing price of ELV's stock was USD 385.10.
The most recent market capitalization for ELV is USD 90.78B.
Based on targets from 10 analysts, the average taret price for ELV is projected at USD 511.33 over the next 12 months.
This means that ELV's stock price may go up by +32.78% over the next 12 months.
We can't find any ETFs which contains Elevance Health Inc's stock.
As per our most recent records Elevance Health Inc has 104,900 Employees.
Elevance Health Inc's registered address is 220 Virginia Avenue, Indianapolis, IN, United States, 46204.
You can get more information about it from Elevance Health Inc's website at https://www.elevancehealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Elevance Health Inc (ELV) Stock
Based on ratings from 10 analysts Elevance Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 13 buy, sell and 4 hold ratings.
ELV stock's dividend yield is 1.67%.
Our analysis grades ELV stock's dividend yield at A+. This means that ELV stock's dividend yield is above 100% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this ELV may be a good dividend stock for its sector.
Based on targets from 10 analysts, the average taret price for ELV is USD 511.33 over the next 12 months. The maximum analyst target price is USD 615 while the minimum anlayst target price is USD 388.
ELV stock's Price/Earning ratio is 15.24.
Our analysis grades ELV stock's Price / Earning ratio at F. This means that ELV stock's Price/Earning ratio is above 60% of the stocks in the Healthcare Plans sector in the NYE exchange.
Based on this ELV may be a overvalued for its sector.
The last closing price of ELV's stock was USD 385.10.
The most recent market capitalization for ELV is USD 90.78B.
Based on targets from 10 analysts, the average taret price for ELV is projected at USD 511.33 over the next 12 months.
This means that ELV's stock price may go up by +32.78% over the next 12 months.
We can't find any ETFs which contains Elevance Health Inc's stock.
As per our most recent records Elevance Health Inc has 104,900 Employees.
Elevance Health Inc's registered address is 220 Virginia Avenue, Indianapolis, IN, United States, 46204.
You can get more information about it from Elevance Health Inc's website at https://www.elevancehealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ELV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
